These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 39008988)

  • 1. X-Linked Myotubular Myopathy and Mitochondrial Function in Muscle and Liver Samples.
    Inoue K; Kato T; Terasaki E; Ishihara M; Fujii T; Aida Y; Murayama K
    Neuropediatrics; 2024 Jul; ():. PubMed ID: 39008988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. X-linked myotubular myopathy mimics hereditary spastic paraplegia in two female manifesting carriers of pathogenic MTM1 variant.
    Kraatari M; Tuominen H; Tuupanen S; Haapaniemi T; Moilanen J; Rahikkala E
    Eur J Med Genet; 2020 Nov; 63(11):104040. PubMed ID: 32805447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous Administration of a MTMR2-Encoding AAV Vector Ameliorates the Phenotype of Myotubular Myopathy in Mice.
    Danièle N; Moal C; Julien L; Marinello M; Jamet T; Martin S; Vignaud A; Lawlor MW; Buj-Bello A
    J Neuropathol Exp Neurol; 2018 Apr; 77(4):282-295. PubMed ID: 29408998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of an MTM1-mutant iPSC line (CRICKi008-A) from an individual with X-linked myotubular myopathy (XLMTM).
    Devito LG; Lionello VM; Muntoni F; Tedesco FS; Healy L
    Stem Cell Res; 2023 Jun; 69():103079. PubMed ID: 36989620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural history of a mouse model of X-linked myotubular myopathy.
    Sarikaya E; Sabha N; Volpatti J; Pannia E; Maani N; Gonorazky HD; Celik A; Liang Y; Onofre-Oliveira P; Dowling JJ
    Dis Model Mech; 2022 Jul; 15(7):. PubMed ID: 35694952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-Linked Myotubular Myopathy: A Novel Mutation Expanding the Genotypic Spectrum of a Phenotypically Heterogeneous Myopathy.
    Carvalho A; Costa C; Pinto M; Taipa R; Gonçalves A; Oliveira ME; Ferreira S; Ribeiro JA
    J Pediatr Genet; 2023 Sep; 12(3):258-262. PubMed ID: 37575650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of Genotype-Phenotype Correlations in X-Linked Myotubular Myopathy and the Use of the Face2Gene Application as an Effective Non-Invasive Diagnostic Tool.
    Kušíková K; Šoltýsová A; Ficek A; Feichtinger RG; Mayr JA; Škopková M; Gašperíková D; Kolníková M; Ornig K; Kalev O; Weis S; Weis D
    Genes (Basel); 2023 Dec; 14(12):. PubMed ID: 38136996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two Cases of X-Linked Myotubular Myopathy with Novel MTM1 Mutations.
    Lee EH; Yum MS; Park SJ; Lee BH; Kim GH; Yoo HW; Ko TS
    J Clin Neurol; 2013 Jan; 9(1):57-60. PubMed ID: 23346162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. rAAV-related therapy fully rescues myonuclear and myofilament function in X-linked myotubular myopathy.
    Ross JA; Tasfaout H; Levy Y; Morgan J; Cowling BS; Laporte J; Zanoteli E; Romero NB; Lowe DA; Jungbluth H; Lawlor MW; Mack DL; Ochala J
    Acta Neuropathol Commun; 2020 Oct; 8(1):167. PubMed ID: 33076971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myotubularin controls desmin intermediate filament architecture and mitochondrial dynamics in human and mouse skeletal muscle.
    Hnia K; Tronchère H; Tomczak KK; Amoasii L; Schultz P; Beggs AH; Payrastre B; Mandel JL; Laporte J
    J Clin Invest; 2011 Jan; 121(1):70-85. PubMed ID: 21135508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenic deep intronic MTM1 variant activates a pseudo-exon encoding a nonsense codon resulting in severe X-linked myotubular myopathy.
    Bryen SJ; Oates EC; Evesson FJ; Lu JK; Waddell LB; Joshi H; Ryan MM; Cummings BB; McLean CA; MacArthur DG; Kornberg AJ; Cooper ST
    Eur J Hum Genet; 2021 Jan; 29(1):61-66. PubMed ID: 32862205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-specific Mtm1 mutagenesis by an AAV-Cre vector reveals that myotubularin is essential in adult muscle.
    Joubert R; Vignaud A; Le M; Moal C; Messaddeq N; Buj-Bello A
    Hum Mol Genet; 2013 May; 22(9):1856-66. PubMed ID: 23390130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs and health resource use in patients with X-linked myotubular myopathy: insights from US commercial claims.
    Sacks NC; Healey BE; Cyr PL; Slocomb T; James E; Beggs AH; Graham RJ
    J Manag Care Spec Pharm; 2021 Aug; 27(8):1019-1026. PubMed ID: 33843254
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of a mutation in the MTM1 gene, associated with X-linked myotubular myopathy, in a Greek family.
    Fidani L; Karagianni P; Tsakalidis C; Mitsiakos G; Hatziioannidis I; Biancalana V; Nikolaidis N
    Hippokratia; 2011 Jul; 15(3):278-9. PubMed ID: 22435031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skeletal Muscle Pathology in X-Linked Myotubular Myopathy: Review With Cross-Species Comparisons.
    Lawlor MW; Beggs AH; Buj-Bello A; Childers MK; Dowling JJ; James ES; Meng H; Moore SA; Prasad S; Schoser B; Sewry CA
    J Neuropathol Exp Neurol; 2016 Feb; 75(2):102-10. PubMed ID: 26823526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of Mtm1 causes cholestatic liver disease in a model of X-linked myotubular myopathy.
    Karolczak S; Deshwar AR; Aristegui E; Kamath BM; Lawlor MW; Andreoletti G; Volpatti J; Ellis JL; Yin C; Dowling JJ
    J Clin Invest; 2023 Sep; 133(18):. PubMed ID: 37490339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of gene replacement therapy with resamirigene bilparvovec (AT132) on skeletal muscle pathology in X-linked myotubular myopathy: results from a substudy of the ASPIRO open-label clinical trial.
    Lawlor MW; Schoser B; Margeta M; Sewry CA; Jones KA; Shieh PB; Kuntz NL; Smith BK; Dowling JJ; Müller-Felber W; Bönnemann CG; Seferian AM; Blaschek A; Neuhaus S; Foley AR; Saade DN; Tsuchiya E; Qasim UR; Beatka M; Prom MJ; Ott E; Danielson S; Krakau P; Kumar SN; Meng H; Vanden Avond M; Wells C; Gordish-Dressman H; Beggs AH; Christensen S; Conner E; James ES; Lee J; Sadhu C; Miller W; Sepulveda B; Varfaj F; Prasad S; Rico S
    EBioMedicine; 2024 Jan; 99():104894. PubMed ID: 38086156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Affected female carriers of MTM1 mutations display a wide spectrum of clinical and pathological involvement: delineating diagnostic clues.
    Biancalana V; Scheidecker S; Miguet M; Laquerrière A; Romero NB; Stojkovic T; Abath Neto O; Mercier S; Voermans N; Tanner L; Rogers C; Ollagnon-Roman E; Roper H; Boutte C; Ben-Shachar S; Lornage X; Vasli N; Schaefer E; Laforet P; Pouget J; Moerman A; Pasquier L; Marcorelle P; Magot A; Küsters B; Streichenberger N; Tranchant C; Dondaine N; Schneider R; Gasnier C; Calmels N; Kremer V; Nguyen K; Perrier J; Kamsteeg EJ; Carlier P; Carlier RY; Thompson J; Boland A; Deleuze JF; Fardeau M; Zanoteli E; Eymard B; Laporte J
    Acta Neuropathol; 2017 Dec; 134(6):889-904. PubMed ID: 28685322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical and genetic study of a manifesting heterozygote with X-linked myotubular myopathy.
    Hammans SR; Robinson DO; Moutou C; Kennedy CR; Dennis NR; Hughes PJ; Ellison DW
    Neuromuscul Disord; 2000 Feb; 10(2):133-7. PubMed ID: 10714588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscle pathology, limb strength, walking gait, respiratory function and neurological impairment establish disease progression in the p.N155K canine model of X-linked myotubular myopathy.
    Goddard MA; Mack DL; Czerniecki SM; Kelly VE; Snyder JM; Grange RW; Lawlor MW; Smith BK; Beggs AH; Childers MK
    Ann Transl Med; 2015 Oct; 3(18):262. PubMed ID: 26605308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.